Skip to content

Comparison of the effect of interventional therapy in symptomatic middle cerebral artery stenosis guided by flow reserve fraction and cerebral angiography

Comparison of the effect of interventional therapy in symptomatic middle cerebral artery stenosis guided by flow reserve fraction and cerebral angiography

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094582
Enrollment
Unknown
Registered
2024-12-25
Start date
2024-12-31
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic cerebrovascular disease

Interventions

FFR guided treatment group :Pd/Pa=0.7 is used for the standard of interventional treatment in FFR guided treatment group.
DSA stenosis rate guided treatment group:DSA stenosis rate ?70% is used for the standard of interventional treatment in DSA guided treatment group.

Sponsors

Beijing Haidian Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Inpatients aged 18-80 years; 2. The degree of middle cerebral artery stenosis was 50%-99%; 3. There were ischemic lesions in the middle cerebral artery territory on the lesion side, which were consistent with cortical or subcortical embolism, hypoperfusion combined with microemboli clearance disorder, or carrier atherosclerotic plaque blocking the perforating branch; 4. All patients voluntarily participated in this study, and patients and their families signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Symptomatic patients with only local perforator artery infarction; 2. Non-atherosclerotic MCA stenosis (e.g., dissection, moyamoya disease, or vasculitis); 3. Patients with heart, kidney and other important organ lesions who cannot tolerate DSA examination; 4. Simultaneous intracranial or extracranial stenosis of ipsilateral internal carotid artery >50%; 5. MRS>=3, life expectancy less than 1 year; 6. Massive cerebral infarction (1/2MCA territory); 7. Patients with known intracranial tumor, infection, hydrocephalus, aneurysm or arteriovenous malformation; 8. Family members are unwilling to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
MRS;

Countries

China

Contacts

Public ContactXiaobing Li

Beijing Haidian Hospital

lxb032918@163.com+86 158 1147 5069

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026